Syndax Pharmaceuticals Inc To Discuss The Data Supporting The Company's Pipeline At The ASH Annual Meeting Transcript - Thomson StreetEvents

Syndax Pharmaceuticals Inc To Discuss The Data Supporting The Company's Pipeline At The ASH Annual Meeting Transcript

Syndax Pharmaceuticals Inc To Discuss The Data Supporting The Company's Pipeline At The ASH Annual Meeting Transcript - Thomson StreetEvents
Syndax Pharmaceuticals Inc To Discuss The Data Supporting The Company's Pipeline At The ASH Annual Meeting Transcript
Published Dec 09, 2024
24 pages (18219 words) — Published Dec 09, 2024
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of SNDX.OQ conference call or presentation 9-Dec-24 3:00pm GMT

  
Brief Excerpt:

...Welcome to the Syndax Investor Meeting. Great to see everyone here early Monday morning at ASH. This is our disclosure statement, and really welcome. My name is Steve Closter, I'm the Chief Commercial Officer at Syndax. I am standing in for our CEO, Michael Metzger, today. Unfortunately, Michael had a death in the family. His mom passed away over the week, and he was actually at ASH and had to run home. I'm sure everybody understands that. He sends his regards as well as his regrets. Michael is available and accessible, as you know, and I'm sure you'll be speaking with him over the coming weeks. We're excited to be here. This is a great meeting for us. We're happy to meet with all of you here today. And what an exciting time to be at Syndax. We've got a great program planned for you. I've got a couple of slides upfront that I'll run through. We have some data that we'll be presenting. A couple of slides at the back and then I'll present. I know all of you have a lot of questions. We have...

  
Report Type:

Transcript

Source:
Company:
Syndax Pharmaceuticals Inc
Ticker
SNDX.OQ
Time
3:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Syndax Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript – 2025-03-13 – US$ 54.00 – Edited Transcript of SNDX.OQ presentation 13-Mar-25 12:30pm GMT

Syndax Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript – 2025-03-04 – US$ 54.00 – Edited Transcript of SNDX.OQ presentation 4-Mar-25 8:10pm GMT

Syndax Pharmaceuticals Inc Q4 2024 Earnings Call Transcript – 2025-03-03 – US$ 54.00 – Edited Transcript of SNDX.OQ earnings conference call or presentation 3-Mar-25 1:00pm GMT

Syndax Pharmaceuticals Inc at Citi Virtual Oncology Leadership Summit Transcript – 2025-02-19 – US$ 54.00 – Edited Transcript of SNDX.OQ presentation 19-Feb-25 2:00pm GMT

Syndax Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript – 2025-01-14 – US$ 54.00 – Edited Transcript of SNDX.OQ presentation 14-Jan-25 6:30pm GMT

Syndax Pharmaceuticals Inc at Citi Global Healthcare Conference Transcript – 2024-12-05 – US$ 54.00 – Edited Transcript of SNDX.OQ presentation 5-Dec-24 4:00pm GMT

Syndax Pharmaceuticals Inc To Discuss The FDA Approval Of Revuforj Call Transcript – 2024-11-15 – US$ 54.00 – Edited Transcript of SNDX.OQ conference call or presentation 15-Nov-24 11:00pm GMT

Syndax Pharmaceuticals Inc at UBS Global Healthcare Conference Transcript – 2024-11-14 – US$ 54.00 – Edited Transcript of SNDX.OQ presentation 14-Nov-24 3:15pm GMT

Syndax Pharmaceuticals Inc To Discuss The Results Of The AUGMENT-101 Trial In R/R mNPM1 AML Transcript – 2024-11-12 – US$ 54.00 – Edited Transcript of SNDX.OQ conference call or presentation 12-Nov-24 1:00pm GMT

Syndax Pharmaceuticals Inc Q3 2024 Earnings Call Transcript – 2024-11-05 – US$ 54.00 – Edited Transcript of SNDX.OQ earnings conference call or presentation 5-Nov-24 9:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Syndax Pharmaceuticals Inc To Discuss The Data Supporting The Company's Pipeline At The ASH Annual Meeting Transcript" Dec 09, 2024. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Syndax-Pharmaceuticals-Inc-To-Discuss-The-Data-Supporting-The-Company-s-Pipeline-At-The-ASH-Annual-Meeting-T16169800>
  
APA:
Thomson StreetEvents. (2024). Syndax Pharmaceuticals Inc To Discuss The Data Supporting The Company's Pipeline At The ASH Annual Meeting Transcript Dec 09, 2024. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Syndax-Pharmaceuticals-Inc-To-Discuss-The-Data-Supporting-The-Company-s-Pipeline-At-The-ASH-Annual-Meeting-T16169800>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.